What does the research say about glycogen storage?
Glycogen storage is the synthesis and retention of branched glucose polymers in liver and skeletal muscle. Here is what the published research and registered trial protocols report on the mechanisms, models and measured
Glycogen storage refers to the synthesis and retention of glycogen, the branched polymer of glucose used as a rapidly mobilisable carbohydrate reserve. Synonyms in the literature include glycogen synthesis, glycogenesis and glycogen deposition; the polymer itself is a glucose homopolymer with alpha-1,4-linked chains and alpha-1,6 branch points, and it is stored in two principal compartments, liver and skeletal muscle. The identifiers that appear in the evidence below are study-level rather than chemical: registered protocols specify dorzagliatin 50 mg twice daily [2], and analytical work describes dried blood spot methods for hCG and IGF-I [1].
The work surveyed here centres on glucose-handling pathways — hepatic glucose metabolism, insulin secretion and glucose tolerance, and the substrate competition between fat and carbohydrate oxidation during exercise — rather than on a single receptor family [2][3][4].
Research Studies
Dorzagliatin and hepatic glycogen storage in pancreatic insufficient cystic fibrosis
A registered crossover trial is designed to determine the pharmacokinetic and pharmacodynamic response to dorzagliatin 50 mg twice daily after 7-day administration in individuals with pancreatic insufficient cystic fibrosis and abnormal glucose tolerance, compared with randomised, double-blind 7-day placebo administration [2]. The stated hypothesis is that dorzagliatin administration will produce significant drug concentrations together with improved glucose tolerance, early-phase insulin secretion, glucagon suppression, and hepatic glycogen storage, the latter assessed during a standardised mixed-meal tolerance test [2]. The population is adults with pancreatic insufficient cystic fibrosis and abnormal glucose tolerance; the outcome of interest is hepatic glycogen storage measured under a controlled feeding challenge rather than under free-living conditions [2].
Exercise intensity, feeding status and muscle glycogen storage
Fat and carbohydrate are described as the two main energy stores available as fuel during exercise, with exercise intensity and feeding status identified as the major determinants of which fuel is used [3]. During prolonged exercise at low to moderate intensity, fat is reported to be the primary fuel, and strategies have been studied with the aim of maximising muscle glycogen storage while elevating fat oxidation during exercise [3]. The rationale given is preservation of limited muscle glycogen stores and consequent improvement in endurance performance [3]. Maximal fat oxidation is defined in that work as the highest rate of fat oxidation across all exercise intensities [3].
hCG, IGF-I and glycogen storage in doping-control analysis
A technical note describes the development of a UHPLC-MS/MS method for analysis of hCG and IGF-I from dried blood spots [1]. The background states that male athletes may use pharmaceutical preparations of hCG to stimulate testosterone production before competition, and IGF-I to stimulate muscle protein synthesis, promote glycogen storage, and improve lipolysis [1]. The analytical focus is on dry matrix microsampling and dried blood spots as strategies to improve doping-control activities, including compound stability, simplification of sample collection and pre-analytic phases, and facilitation of automation [1].
Irisin gene delivery and hepatic glucose metabolism in Akita mice
Work in Akita mice investigated whether the exercise-induced hormone irisin can directly regulate hepatic glucose metabolism and manage diabetic phenotype under insulin-deficient conditions [4]. The reported finding is that irisin gene delivery elicited sustained amelioration of diabetes in that mouse model via insulin-independent regulation of hepatic glucose metabolism [4]. This is an animal study; the mechanism described is hepatic and insulin-independent, and it does not establish an effect in humans [4].
Skeletal muscle biomass as a fate of glucose
A review argues that glucose is traditionally viewed as a substrate for ATP production and glycogen storage in skeletal muscle, and presents evidence that glucose also serves as a building block for biomass synthesis in proliferating muscle satellite (stem) cells and in hypertrophying skeletal muscle fibres [5]. The authors draw parallels to anabolic processes in other systems [5]. This is a review of the literature rather than a primary experimental study, and it reframes glycogen storage as one of several competing fates for glucose within muscle [5].
Comparison of reported contexts for glycogen storage
| Context | Model or population | Reported measure or aim | Source |
|---|---|---|---|
| Dorzagliatin 50 mg twice daily vs placebo | Pancreatic insufficient cystic fibrosis with abnormal glucose tolerance | Hepatic glycogen storage during mixed-meal tolerance test | [2] |
| Exercise fuel selection | Exercise studies at low to moderate intensity | Maximise muscle glycogen storage, elevate fat oxidation | [3] |
| IGF-I use in sport | Male athletes (described background) | Glycogen storage among stated effects | [1] |
| Irisin gene delivery | Akita mice | Hepatic glucose metabolism, insulin-independent | [4] |
| Glucose as biomass precursor | Muscle satellite cells and hypertrophying fibres | Biomass synthesis alongside glycogen storage | [5] |
Where the evidence is animal-only or non-clinical
The irisin work is animal-only, conducted in Akita mice [4]. The biomass argument is a review drawing on cell and tissue observations rather than a controlled human trial [5]. The hCG and IGF-I material is an analytical method development note, and its statements about athlete use and about glycogen storage are background framing rather than measured outcomes [1]. The dorzagliatin and exercise-fuel items are registered protocols and study descriptions; the dorzagliatin hypothesis concerns hepatic glycogen storage as an assessed endpoint, and the exercise material concerns muscle glycogen storage as a strategy target [2][3].
If you are reading this for personal health reasons
The materials discussed on this page are supplied for laboratory research use only, and we do not provide dosing information or medical guidance of any kind. Nothing here is a recommendation to use any compound, and no statement on this page should be read as a promise of any outcome. Anyone considering a compound for themselves should speak to a licensed clinician.
Sources
- [1] Technical note: Development of a UHPLC-MS/MS method for the analysis of hCG and IGF-I from dried blood spots: A preliminary study — https://pubmed.ncbi.nlm.nih.gov/42385550/
- [2] Dorzagliatin in Pancreatic Insufficient Cystic Fibrosis — https://clinicaltrials.gov/study/NCT06995651
- [3] Maximal Fat Oxidation and Fuel Use During Exercise — https://clinicaltrials.gov/study/NCT04678713
- [4] Irisin Gene Delivery Elicits Sustained Amelioration of Diabetes in Akita Mice via Insulin-Independent Regulation of Hepatic Glucose Metabolism — https://pubmed.ncbi.nlm.nih.gov/42627513/
- [5] Skeletal muscle biomass as an underappreciated fate of glucose — https://pubmed.ncbi.nlm.nih.gov/42405421/